Reshape Lifesciences Inc Revenue Growth Rates (RSLS), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Reshape Lifesciences Inc  (NASDAQ: RSLS)
 

RSLS's Revenue Growth by Quarter and Year

Reshape Lifesciences Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/RSLS/growth
https://api.csimarket.com/api/v1/companies/RSLS/fundamentals
https://api.csimarket.com/api/v1/companies/RSLS/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
RSLS Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 0.03
FY 0.03

RSLSs Annual Revenue
Reshape Lifesciences Inc's Revenue in the fiscal year 2024 $ 7.06 millions
Reshape Lifesciences Inc's Revenue in the fiscal year 2023 $ 8.55 millions
Reshape Lifesciences Inc's Revenue in the fiscal year 2022 $ 11.24 millions
Reshape Lifesciences Inc's Revenue in the fiscal year 2021 $ 13.60 millions
Reshape Lifesciences Inc's Revenue in the fiscal year 2020 $ 11.30 millions




RSLS Revenue first quarter 2026 Y/Y Growth Comment
Reshape Lifesciences Inc reported drop in Revenue in the first quarter 2026 by -96.33% to $ 0.03 millions, from the same quarter in 2025.
The fall in the first quarter 2026 Reshape Lifesciences Inc's Revenue compares unfavorably to the Company's average Revenue doubling of 137.58%.

Looking into first quarter 2026 results within Major Pharmaceutical Preparations industry 202 other companies have achieved higher Revenue growth. While Reshape Lifesciences Inc' s Revenue meltdown of -96.33% ranks overall at the positon no. 4006 in the first quarter 2026.


RSLS Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March -96.33 %
FY   -

Financial Statements
Reshape Lifesciences Inc's first quarter 2026 Revenue $ 0.03 millions RSLS's Income Statement
Reshape Lifesciences Inc's first quarter 2025 Revenue $ 0.86 millions Quarterly RSLS's Income Statement


RSLS Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 5.3 %
FY (Year on Year)   -


Back to RSLS Growth rate Comparisons >> Back to RSLS Growth rate Comparisons >>


Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #203
Healthcare Sector #575
Overall #4006

Revenue Y/Y Growth Statistics
High Average Low
2272.62 % 137.58 % -100 %
 
Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #203
Healthcare Sector #575
Overall #4006
Revenue Y/Y Growth Statistics
High Average Low
2272.62 % 137.58 % -100 %
 

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Reshape Lifesciences Inc's Q/Q Revenue Growth